Literature DB >> 21880411

Developmental, cellular and molecular biology of benign prostatic hyperplasia.

William A Ricke, Jill A Macoska, Gerald R Cunha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21880411      PMCID： PMC3415972          DOI： 10.1016/j.diff.2011.08.005

Source DB:  PubMed          Journal:  Differentiation        ISSN： 0301-4681            Impact factor:   3.880


× No keyword cloud information.
  4 in total

1.  Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays.

Authors:  Kulkarni Prakash; Gregorio Pirozzi; Michael Elashoff; William Munger; Iwao Waga; Rajiv Dhir; Yoshiyuki Kakehi; Robert H Getzenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis.

Authors:  Jun Luo; Thomas Dunn; Charles Ewing; Jurga Sauvageot; Yidong Chen; Jeffrey Trent; William Isaacs
Journal:  Prostate       Date:  2002-05-15       Impact factor: 4.104

3.  The cost of treating the 10 most prevalent diseases in men 50 years of age or older.

Authors:  Thomas C Fenter; Michael James Naslund; Manan B Shah; Michael T Eaddy; Libby Black
Journal:  Am J Manag Care       Date:  2006-03       Impact factor: 2.229

4.  The development of human benign prostatic hyperplasia with age.

Authors:  S J Berry; D S Coffey; P C Walsh; L L Ewing
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450
  4 in total
  1 in total

1.  Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway.

Authors:  Jean-Nicolas Cornu; Etienne Audet-Walsh; Sarah Drouin; Pierre Bigot; Antoine Valeri; Georges Fournier; Abdel-Rahmène Azzouzi; Morgan Roupret; Luc Cormier; Stephen Chanock; Chantal Guillemette; Olivier Cussenot; Eric Lévesque; Géraldine Cancel-Tassin
Journal:  World J Urol       Date:  2016-06-08       Impact factor: 4.226
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.